About UCSF Search UCSF UCSF Medical Center

Sabine Mueller, MD, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
mueller_sabine

Assistant Professor of Clinical Neurology, UCSF

muellers@neuropeds.ucsf.edu

Phone: (415) 502-7301
Box 0663, UCSF
San Francisco, CA 94143-0663

View on UCSF Profiles


Additional Websites


Education

College, University of Hamburg, Germany  M.S.,  01/95,  Biochemistry
MD/PhD program, University of Hamburg,  M.D./Ph.D.,  01/03,  Chemistry
Harvard Medical School, Boston,  Intern,  01/05,  Pediatrics
Harvard Medical School, Boston,  Resident,  01/06,  Pediatrics
UCSF,  Clinical  Fellow,  06/09,  Child Neurology
UCSF,  Clinical  Fellow,  06/10,  Neuro-Oncology


Professional Experience

  • 2010-present
    UCSF Assistant Professor Clinical X Neurological Surgery
  • 2010-present
    UCSF Assistant Professor Clinical X Pediatrics
  • 2011-present
    UCSF Director Multi-disciplinary Brain Tumor Clinic
  • 2012-present
    UCSF Co-Project Leader Pacific Pediatric Neuro-Oncology Consortium (PNOC)
  • 2013-present
    UCSF Director of the Pediatric Brain Tumor Center Department of Neurology, Neurosurgery and Pediatrics

Honors & Awards

  • 1997
    Center of Molecular Neurobiology (ZMNH) Predoctoral Fellowship, Hamburg,Germany
  • 1998
    European Society of Neurobiology research/travel award, Berlin, Germany
  • 1999
    Center of Molecular Neurobiology (ZMNH) AACR research/travel award,Philadelphia, PA
  • 1999
    Bauer Stiftung Predoctoral Fellowship, Hamburg, Germany
  • 2007
    Travel scholarship to attend the Annual Meeting of Neurology
  • 2008
    Chief Resident, Department of Neurology, UCSF
  • 2010
    Research Award from the Campini Foundation
  • 2011
    BRAIN SPORE Career Development Award
  • 2012
    Research Award from the Matthew Larson Foundation
  • 2012
    Hellman Family Research Award
  • 2012
    University of California Cancer Coordinating Committee Award
  • 2012
    KL2 CTSI Award

Selected Publications

  1. Mueller S, Hashizume R, Yang X, Kolkowitz I, Olow AK, Phillips J, Smirnov I, Tom MW, Prados MD, James CD, Berger MS, Gupta N, Haas-Kogan DA. Targeting Wee1 for the treatment of pediatric high-grade gliomas. Neuro Oncol. 2014 Mar; 16(3):352-60.
    View on PubMed
  2. Abedalthagafi M, Phillips JJ, Kim GE, Mueller S, Haas-Kogen DA, Marshall RE, Croul SE, Santi MR, Cheng J, Zhou S, Sullivan LM, Martinez-Lage M, Judkins AR, Perry A. The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas. Mod Pathol. 2013 Nov; 26(11):1425-32.
    View on PubMed
  3. Mueller S, Fullerton HJ, Stratton K, Leisenring W, Weathers RE, Stovall M, Armstrong GT, Goldsby RE, Packer RJ, Sklar CA, Bowers DC, Robison LL, Krull KR. Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys. 2013 Jul 15; 86(4):649-55.
    View on PubMed
  4. Cage TA, Samagh SP, Mueller S, Nicolaides T, Haas-Kogan D, Prados M, Banerjee A, Auguste KI, Gupta N. Feasibility, safety, and indications for surgical biopsy of intrinsic brainstem tumors in children. Childs Nerv Syst. 2013 Aug; 29(8):1313-9.
    View on PubMed
  5. Mueller S, Sear K, Hills NK, Chettout N, Afghani S, Gastelum E, Haas-Kogan D, Fullerton HJ. Risk of first and recurrent stroke in childhood cancer survivors treated with cranial and cervical radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Jul 15; 86(4):643-8.
    View on PubMed
  6. Phillips JJ, Aranda D, Ellison DW, Judkins AR, Croul SE, Brat DJ, Ligon KL, Horbinski C, Venneti S, Zadeh G, Santi M, Zhou S, Appin CL, Sioletic S, Sullivan LM, Martinez-Lage M, Robinson AE, Yong WH, Cloughesy T, Lai A, Phillips HS, Marshall R, Mueller S, Haas-Kogan DA, Molinaro AM, Perry A. PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma. Brain Pathol. 2013 Sep; 23(5):565-73.
    View on PubMed
  7. Mueller S, Bhargava S, Molinaro AM, Yang X, Kolkowitz I, Olow A, Wehmeijer N, Orbach S, Chen J, Matthay KK, Haas-Kogan DA. Poly (ADP-Ribose) polymerase inhibitor MK-4827 together with radiation as a novel therapy for metastatic neuroblastoma. Anticancer Res. 2013 Mar; 33(3):755-62.
    View on PubMed
  8. Huang T, Mueller S, Rutkowski MJ, Han SJ, Bloch O, Barani IJ, Parsa AT, Chang SM. Multidisciplinary care of patients with brain tumors. Surg Oncol Clin N Am. 2013 Apr; 22(2):161-78.
    View on PubMed
  9. Hashizume R, Smirnov I, Liu S, Phillips JJ, Hyer J, McKnight TR, Wendland M, Prados M, Banerjee A, Nicolaides T, Mueller S, James CD, Gupta N. Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment. J Neurooncol. 2012 Dec; 110(3):305-13.
    View on PubMed
  10. Mueller S, Phillips J, Onar-Thomas A, Romero E, Zheng S, Wiencke JK, McBride SM, Cowdrey C, Prados MD, Weiss WA, Berger MS, Gupta N, Haas-Kogan DA. PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome. Neuro Oncol. 2012 Sep; 14(9):1146-52.
    View on PubMed
  11. Cage TA, Mueller S, Haas-Kogan D, Gupta N. High-grade gliomas in children. Neurosurg Clin N Am. 2012 Jul; 23(3):515-23.
    View on PubMed
  12. Schoenfeld A, Pekmezci M, Barnes MJ, Tihan T, Gupta N, Lamborn KR, Banerjee A, Mueller S, Chang S, Berger MS, Haas-Kogan D. The superiority of conservative resection and adjuvant radiation for craniopharyngiomas. J Neurooncol. 2012 May; 108(1):133-9.
    View on PubMed
  13. Mueller S, Yang X, Sottero TL, Gragg A, Prasad G, Polley MY, Weiss WA, Matthay KK, Davidoff AM, DuBois SG, Haas-Kogan DA. Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: efficacy and underlying mechanisms. Cancer Lett. 2011 Jul 28; 306(2):223-9.
    View on PubMed
  14. More SS, Itsara M, Yang X, Geier EG, Tadano MK, Seo Y, Vanbrocklin HF, Weiss WA, Mueller S, Haas-Kogan DA, Dubois SG, Matthay KK, Giacomini KM. Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems. Clin Cancer Res. 2011 Apr 15; 17(8):2339-49.
    View on PubMed
  15. Prasad G, Sottero T, Yang X, Mueller S, James CD, Weiss WA, Polley MY, Ozawa T, Berger MS, Aftab DT, Prados MD, Haas-Kogan DA. Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide. Neuro Oncol. 2011 Apr; 13(4):384-92.
    View on PubMed
  16. Mueller S, Polley MY, Lee B, Kunwar S, Pedain C, Wembacher-Schröder E, Mittermeyer S, Westphal M, Sampson JH, Vogelbaum MA, Croteau D, Chang SM. Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study. J Neurooncol. 2011 Jan; 101(2):267-77.
    View on PubMed
  17. Mueller S, Matthay KK. Neuroblastoma: biology and staging. Curr Oncol Rep. 2009 Nov; 11(6):431-8.
    View on PubMed
  18. Mueller S, Chang S. Pediatric brain tumors: current treatment strategies and future therapeutic approaches. Neurotherapeutics. 2009 Jul; 6(3):570-86.
    View on PubMed
  19. Dubal DB, Mueller S, Ruben BS, Engstrom JW, Josephson SA. T-cell lymphoproliferative disorder following mycophenolate treatment for myasthenia gravis. Muscle Nerve. 2009 Jun; 39(6):849-50.
    View on PubMed

Go to UCSF Profiles, powered by CTSI